Across TCGA pan-cancer cohorts, CES5AP1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CES5AP1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher CES5AP1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CES5AP1 expression acts as an unfavorable survival marker.

OV are the cancer types where CES5AP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	II,III,IV	0.140	0.541	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CES5AP1 tumor-vs-normal RNA expression · all CES5AP1 data types